Healthcare startups continue to be favored by investors, as a total of four different biotech firms in China raised a combined of over RMB500 million yuan in a day. Gene’s Key has recently completed RMB230 million yuan C round of financing. The investors in this round of financing are Huagai Capital, Xingze Capital and Yuansheng […]
Four Chinese Biotech Firms Raise Over RMB500 Million In Funding comes from China Money Network: Primary Data for China’s Primary Markets! All Rights Reserved.